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O2 is the ultimate electron acceptor for mito-
chondrial respiration, a process catalyzed by
cytochrome c oxidase (COX). In yeast, COX
subunit composition is regulated by COX5a
and COX5b gene transcription in response to
high and low O2, respectively. Here we demon-
strate that in mammalian cells, expression of
the COX4-1 and COX4-2 isoforms is O2 regu-
lated. Under conditions of reduced O2 availabil-
ity, hypoxia-inducible factor 1 (HIF-1) recipro-
cally regulates COX4 subunit expression by
activating transcription of the genes encoding
COX4-2 and LON, a mitochondrial protease
that is required for COX4-1 degradation. The ef-
fects of manipulating COX4 subunit expression
on COX activity, ATP production, O2 consump-
tion, and reactive oxygen species generation
indicate that the COX4 subunit switch is a
homeostatic response that optimizes the effi-
ciency of respiration at different O2 concentra-
tions. Thus, mammalian cells respond to hyp-
oxia by altering COX subunit composition, as
previously observed in yeast, but by a com-
pletely different molecular mechanism.
INTRODUCTION
The goal of oxidative phosphorylation is the transfer of
electrons through a series of acceptor cytochromes in or-
der to generate a proton gradient within the inner mito-
chondrial membrane. The potential energy of this gradient
is used to synthesize ATP. O2 is the ultimate electron ac-
ceptor, resulting in the production of H2O in a process
that is catalyzed by cytochrome c oxidase (COX; complexIV). This process is not completely efficient; electron trans-
fer to O2 may occur at complex I or III, resulting in gener-
ation of reactive oxygen species (ROS) that oxidize cellular
proteins, lipids, and nucleic acids and, by doing so, cause
cell dysfunction or death.
COX, which is located in the inner mitochondrial mem-
brane, is a dimer in which each monomer consists of 13
subunits (Tsukihara et al., 1996). Subunits I, II, and III are
encoded by themitochondrial genome, constitute the cat-
alytic core of the enzyme, and are highly conserved in eu-
karyotes. The crystal structure of bovine COX revealed
that subunit IV (COX4) interacts with both COX1 and
COX2 (Tsukihara et al., 1996). In mammalian cells, the first
step of COX assembly is the association of COX1 with
COX4 (Nijtmans et al., 1998). Within the complex, COX4
binds ATP, leading to allosteric inhibition of COX activity
at high ATP/ADP ratios and demonstrating a regulatory
role for COX4 (Napiwotzki and Kadenbach, 1998).
Molecular modeling indicates that the spatial relation-
ships of yeast homologsofCOX1,COX2, andCOX4 (which
in yeast is designated COX5) are similar to the mammalian
complex (Burke and Poyton, 1998). The yeast genome
contains two genes encoding COX5 proteins, which
show reciprocal patternsof expression: at highO2concen-
trations,COX5a transcription is activated andCOX5b tran-
scription is repressed, whereas at low O2 concentrations,
COX5a transcription is inactivated and COX5b transcrip-
tion is derepressed (Lowry and Zitomer, 1984; Forsburg
and Guarente, 1989; Kwast et al., 1998). Substitution of
COX5b for COX5a increases the turnover number (TNmax)
of COX by increasing the rate of electron transfer from
heme a to the binuclear reaction center within COX1
(Waterland et al., 1991; Allen et al., 1995). Mammals pos-
sess paralagous genes encoding alternative isoforms of
COX6, COX7a, COX8, and COX4 (Hutteman et al., 2001).
Although tissue-specific expression of these genes has
been demonstrated, neither molecular nor physiological
regulatory mechanisms have been elucidated.Cell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc. 111
Figure 1. Expression of COX 4-1 and
COX 4-2 mRNA
(A) COX4-2 mRNA expression was analyzed by
RT-PCR in Hep3B, HeLa, Hct116, and A594
cells that were cultured under nonhypoxic
(20% O2) or hypoxic (1% O2) conditions for
24 hr.
(B) COX4-1 and COX4-2 mRNA expression
was analyzed in primary cultures of mouse pul-
monary artery smoothmuscle cells (mPASMC).
(C) Immunoblot assay of COX4-2 and b-actin in
HeLa cells exposed to 20% or 1% O2 for 24 hr
is shown.
(D) Quantitative real-time (qrt) RT-PCR analysis
of COX4-1, COX4-2, and GLUT1 mRNA ex-
pression (mean ± SEM) in Hep3B and HeLa
cells exposed to: 20% O2 with no treatment
(No); 1% O2 (Hy); or 20% O2 in the presence
of CoCl2 (Co), desferrioxamine (Df), or dimethy-
loxalylglycine (Do).
(E) qrtPCR was performed to analyze expres-
sion of COX4-2 mRNA (mean ± SEM) in brain
(Br), heart (He), lung (Lu), liver (Li), and kidney
(Ki) tissue from mice (n = 3 each) exposed to
21% or 10% O2 for 3 weeks.Hypoxia-inducible factor 1 (HIF-1) is a transcriptional
activator that functions as a master regulator of oxygen
homeostasis in all metazoan species. Previous studies
have demonstrated that HIF-1 transactivates genes en-
coding glucose transporters and glycolytic enzymes in re-
sponse to reduced O2 availability (Semenza et al., 1996;
Iyer et al., 1998; Seagroves et al., 2001). HIF-1 is a hetero-
dimeric protein composed of a constitutively expressed
HIF-1b subunit and anO2-regulated HIF-1a or HIF-2a sub-
unit (Wang et al., 1995; Jiang et al., 1996; Tian et al., 1997;
Wiesener et al., 1998). Under aerobic conditions, HIF-1a
and HIF-2a are subjected to prolyl hydroxylation by en-
zymes that utilize O2 as a substrate (Ivan et al., 2001; Jaak-
kola et al., 2001; Yu et al., 2001). Hydroxylation is required
for binding of the von Hippel-Lindau (VHL) protein (Max-
well et al., 1999), which targets HIF-1a and HIF-2a for
ubiquitination and proteasomal degradation (Salceda
and Caro, 1997). The interaction of HIF-1a with the coac-
tivators CBP and p300 is blocked byO2-dependent aspar-
aginyl hydroxylation mediated by FIH-1 (Lando et al.,
2002). Under hypoxic conditions, the rate of hydroxylation
declines, leading to HIF-1 activation and thus providing
a mechanism by which changes in oxygenation are trans-
duced to the nucleus as changes in gene expression. In
this study, we tested the hypothesis that in mammalian
cells the expression of COX4-1 and COX4-2 is O2 regu-
lated through the activity of HIF-1.
RESULTS
COX4-2 mRNA Expression Is Induced by Hypoxia
To investigate whether COX4-2 mRNA expression is O2
regulated in human cells, Hep3B (liver), HeLa (uterus),
Hct116 (colon), and A594 (lung) cells were incubated at112 Cell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc.20% or 1% O2 for 24 hr. COX4-2 mRNA expression was
induced under hypoxic conditions in all four cell lines as
determined by reverse transcriptase (RT)-PCR (Figure 1A).
Hypoxia-induced expression of COX4-2 mRNA was also
observed in primary cultures of mouse pulmonary artery
smooth muscle cells (mPASMC; Figure 1B). COX4-2 pro-
tein expression was induced in hypoxic HeLa cells as de-
termined by immunoblot assay (Figure 1C) using an anti-
body that specifically recognizes COX4-2 (Figure S1).
COX4-1 mRNA expression was not O2 regulated in
mPASMC, HeLa, or Hep3B cells as determined by both
conventional RT-PCR (Figures 1B and S2) and quantita-
tive real-time RT-PCR (qrtPCR; Figure 1D). COX4-2, but
not COX4-1, mRNA expression was induced in HeLa
and Hep3B cells exposed to CoCl2, desferrioxamine
(DFX), or dimethyloxalylglycine (DMOG), which are in-
ducers of HIF-1a expression that inhibit hydroxylase activ-
ity (Epstein et al., 2001; Jaakkola et al., 2001) and thereby
increase the expression of mRNAs encoded by HIF-1 tar-
get genes such as GLUT1 (Figures 1D and S2). COX4-2
mRNA expression was increased in liver and lung tissue
frommice exposed to 10%O2 for 3 weeks relative to con-
trol mice exposed to room air (21% O2), indicating that
COX4-2 induction is a physiological response to hypoxia
(Figure 1E). Taken together the data shown in Figure 1
demonstrate that expression of the COX4I2 gene, which
encodes COX4-2, is induced in response to hypoxia and
suggest that this response may be regulated by HIF-1.
Identification of Hypoxia-Response Elements
in the Human COX4I2 gene
We searched the human COX4I2 gene for matches to
a consensus sequence, which was generated from hyp-
oxia-response elements (HREs) in the EPO, ALDA, Vegf,
Figure 2. Identification of Hypoxia-Response Elements in the COX4I2 Gene
(A) Nucleotide sequences matching the consensus hypoxia-response element (HRE) from seven mammalian genes [50-RCGTG(N)1-8CACAG-30] are
present in the 50-flanking region (HRE1) and intron 1 (HRE2) within a 2.1 kb DNA fragment of the human COX4I2 gene. The nucleotide sequences are
numbered in relation to the transcription initiation site, which is designated ‘‘+1.’’ The nucleotides that were mutated to eliminate HIF-1 binding are
shown in red.
(B) Luciferase reporter genes containing the 2.1 kb COX4I2 gene fragment or an analogous 2.7 kb COX4I1 gene fragment were transfected into 293
cells and cultured under the following conditions for 24 hr: 20%O2; 1%O2; or 20%O2 in the presence of 100 mMCoCl2 or desferrioxamine (DFX). For
each reporter, mean luciferase activity under each experimental condition is shown (± SEM, n = 3) relative to the activity in control cells (20% O2).
(C) Immunoblot assay of HIF-1a, HIF-2a, HIF-1b, and b-actin protein in HeLa and 293 cells cultured under nonhypoxic (20% O2) or hypoxic (1% O2)
conditions.
(D and E) Luciferase reporter genes containing full-length 2.1 kbCOX4I2 gene fragment with both HREs (black ovals) spanning exon 1 (open rectangle)
or deletion constructs with only a single HREwere cotransfected into HeLa (D) or 293 (E) cells with expression vector encoding HIF-1a or HIF-2a, then
incubated at 20%O2 or cotransfected with empty vector and incubated at 20% or 1%O2 for 24 hr. For each experimental condition, mean luciferase
activity is shown (± SEM, n = 3) relative to activity in cells transfected with empty vector and incubated at 20% O2.CP, ID2, BNIP3, and NOXA genes (Semenza et al., 1996;
Shima et al., 1996; Bruick, 2000; Mukhopadhyay et al.,
2000; Kim et al., 2004; Lofstedt et al., 2004) and consisted
of the core HIF-1-binding site 50-RCGTG-30 followed, after
1–8 nucleotides, by a CAC sequence (consensus, 50-CA
CAG-30). Candidate HREswere identified in the 50-flanking
region (HRE1) and intron 1 (HRE2) ofCOX4I2 (Figure 2A). A
2.1 kb DNA fragment spanning these HREs was inserted
into the promoterless luciferase reporter plasmid pGL2-
Basic. A second plasmid containing 2.7 kb spanning theanalogous region of the human COX4I1 gene, which en-
codes COX4-1, was also constructed. The reporter plas-
mids were transfected into human embryonic kidney 293
cells, which were incubated under four conditions: control
nonhypoxic conditions (20% O2); hypoxia (1% O2); and
nonhypoxic conditions in the presence of 100 mM CoCl2
or DFX. Analysis of cell lysates 24 hr later revealed that
COX4I2 promoter activity was induced by hypoxia,
CoCl2, or DFX, whereasCOX4I1 promoter activity was un-
affected (Figure 2B). These results are consistent with theCell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc. 113
analyses of COX4-1 and COX4-2 mRNA expression (Fig-
ure 1) and indicate that hypoxia selectively induces
COX4I2 gene transcription.
Immunoblot assays revealed that HIF-1a protein ex-
pression was induced by hypoxia in HeLa and 293 cells,
whereas HIF-2a expression was poorly induced in hyp-
oxic 293 cells (Figure 2C). COX4I2 promoter activity in
HeLa cells was dramatically increased by hypoxia or co-
transfection of an expression vector encoding HIF-2a,
whereas cotransfection of an expression vector encoding
HIF-1a had a more modest effect (Figures 2D and S4) de-
spite high levels of HIF-1a protein in transfected cells
(Figure S3). In 293 cells, COX4I2 promoter activity was
greatly increased by cotransfection of a HIF-2a expres-
sion vector, whereas hypoxia or cotransfection of HIF-1a
expression vector had a more modest effect (Figures 2E
and S4). These data suggest that HIF-2a is a more potent
transactivator of the COX4I2 promoter than HIF-1a, and
the immunoblot data (Figure 2C) suggest that the more
modest effect of hypoxia on COX4I2 promoter activity in
293 cells is due to the limited induction of HIF-2a expres-
sion. Analysis of deletion constructs containing only HRE1
or HRE2 suggested that both sequences are required
for maximal induction of COX4I2 promoter activity in
response to hypoxia or overexpression of HIF-1a or
HIF-2a (Figures 2D, 2E, and S4).
The data presented in Figure 2 suggest that both HIF-1a
and HIF-2a can contribute to increased COX4I2 promoter
activity in hypoxic cells. To further test this hypothesis,
HeLa and 293 cells were cotransfected with pCEP4-HIF-
1aDN, which encodes a dominant-negative form of HIF-
1a that competes with endogenous HIF-1a and HIF-2a
for dimerization with HIF-1b but results in transcriptionally
inactive heterodimers (Jiang et al., 1996). HIF-1aDN in-
hibited hypoxia-induced COX4I2 promoter activity in
a dose-dependent manner in both 293 and HeLa cells
(Figure 3A), which is similar to its effect on reporter plas-
mid p2.1 (Figure S5), which contains a HIF-1-dependent
HRE from the ENO1 gene (Semenza et al., 1996).
To determine the effect of specifically interfering with
HIF-1a or HIF-2a expression, HeLa and 293 cells were
transfected with: empty vector (EV); expression vector en-
coding short hairpin RNA (shRNA) directed against HIF-1a
(Shr-HIF-1a) or HIF-2a (Shr-HIF-2a); or vector encoding
a scrambled negative control sequence (Scr). Immunoblot
assays revealed that target protein expression was
reduced in Shr-transfected cells (Figure S6). The cells
were cotransfected with reporter plasmid p2.1 or the
COX4I2 promoter reporter. Shr-HIF-1a significantly in-
hibited hypoxia-induced p2.1 in both HeLa and 293 cells,
whereas Shr-HIF-2a had no significant effect on hypoxia-
induced p2.1 activity in HeLa or 293 cells (Figure S7). In
contrast, Shr-HIF-2a significantly inhibited hypoxia-in-
duced COX4I2 promoter activity in HeLa cells but not in
293 cells (Figure 3B), which have low HIF-2a expression
(Figure 2C). These data indicate that: different gene pro-
moters (ENO1 versus COX4I2) are differentially regulated
by HIF-1a versus HIF-2a and that regulation of the same114 Cell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc.gene (COX4I2) in different cell types (293 versus HeLa)
may vary depending upon the extent to which HIF-2a is
induced by hypoxia.
To demonstrate that the HIF-1-binding sites in HRE1
and HRE2 were required for hypoxia-induced COX4I2
promoter activity, CG/AA mutations that destroy the
HIF-1-binding sites were introduced into the HREs (Fig-
ure 2A). Mutation of HRE2 resulted in a partial loss of ac-
tivity, whereas mutation of both HREs resulted in a com-
plete loss of hypoxia-induced COX4I2 promoter activity
in both HeLa and 293 cells (compare Figure 3C with Fig-
ures 2D and 2E).
To demonstrate that HIF-1 binds to these sequences
within living cells, chromatin immunoprecipitation (ChIP)
assays were performed using DFX-treated HeLa and
293 cells. Binding of HIF-2a to HRE1 and HRE2 in HeLa
cells and binding of HIF-1a to HRE2 in 293 cells was dem-
onstrated when PCR was performed using a single set of
flanking primers (Figures 3D and 3E). A more sensitive but
nonquantitative nested PCR was required to demonstrate
the binding of HIF-1a to HRE2 in HeLa cells. No PCRprod-
uct was detected when nonspecific IgG was used instead
of specific antibody against HIF-1a or HIF-2a for ChIP
assay of DFX-treated cells or when chromatin from un-
treated cells was used for ChIP with antibodies against
HIF-1a or HIF-2a (data not shown). The data presented
in Figures 1–3 show that COX4I2 expression is induced
by HIF-1 and that HIF-2a-containing heterodimers prefer-
entially, but not exclusively, bind to two HREs within the
50-flanking region and intron 1 to activate gene transcrip-
tion.
Regulation of COX4-1 Protein Levels by HIF-1
We next investigated whether HIF-1 regulates COX4-1
protein levels using a subunit-specific antibody (Fig-
ure S1). HeLa and Hct116 cells were cultured for 24 or
48 hr in the presence or absence of CoCl2. Exposure of
the cells to CoCl2 induced increased HIF-1a expression
as expected but also resulted in a dramatic reduction in
COX4-1 protein levels, whereas b-actin levels were un-
affected (Figure 4A). A time course analysis of CoCl2-
treated HeLa cells revealed a gradual reduction in
COX4-1 protein levels over 24 hr, whereas b-actin protein
levels were unchanged (Figure 4B). In addition to CoCl2,
the HIF-1 hydroxylase inhibitors DMOG and dihydroxy-
benzoate (DHB) increased HIF-1a and decreased
COX4-1 protein levels (Figure 4C).
To investigate whether the effect of hydroxylase inhibi-
tors on COX4-1 was due to their induction of HIF-1 activ-
ity, we utilized two other HIF-1 gain-of-function (GOF)
models. First, we analyzed RCC4 human renal carcinoma
cells in which VHL loss-of-function (LOF) results in consti-
tutive high-level expression of HIF-1a andHIF-2a (Hu et al.,
2003). In these cells, COX4-1 protein levels were low even
in the absence of CoCl2 treatment, whereas in a subclone
stably transfected with a VHL expression vector to inhibit
HIF-1a and HIF-2a expression under nonhypoxic con-
ditions, COX4-1 protein levels were increased in the
Figure 3. Involvement of HIF-1a and HIF-2a in Transactivation of the COX4I2 Promoter
(A) Cells were transfected with theCOX4I2-luciferase reporter and increasing amounts (in ng) of expression vector pCEP4-HIF-1aDN, which encodes
a dominant-negative form of HIF-1a, and were incubated at 20% or 1% O2 for 24 hr. Mean luciferase activity is shown (± SEM, n = 3) relative to the
activity in cells transfected with no pCEP4-HIF-1aDN (200 ng of empty vector pCEP4) and incubated at 20% O2.
(B) HeLa and 293 cells were cotransfected withCOX4I2-luciferase reporter and empty vector (EV) or vector encoding a short-hairpin RNA that blocks
the expression of HIF-1a (Shr-HIF-1a) or HIF-2a (Shr-HIF-2a) then incubated for 24 hr at 20% O2 (red bars) or 1% O2 (blue bars). Mean luciferase
activity is shown (± SEM, n = 3) relative to cells transfected with EV and incubated at 20% O2.
(C) HeLa and 293 cells were cotransfected with reporter plasmids containing a CG/AAmutation in the putative HIF-1-binding site of HRE1 or HRE2
(slashed oval) in the presence of: 20%O2; 1%O2; or 20%O2 with cotransfected HIF-1a or HIF-2a expression vector. Mean luciferase activity (± SEM,
n = 3) was determined.
(D and E) Chromatin immunoprecipitation (ChIP) assays were performed using the indicated primers (D) and antibodies (E) to demonstrate binding of
HIF-1a or HIF-2a to HRE1 and HRE2 in desferrioxamine-treated HeLa or 293 cells. The first PCR was performed using P1-P2 and P4-R1 primer pairs
for HRE1 and HRE2, respectively. The second PCR was performed using P3-P2 and P4-P5 primer pairs.absence but not in the presence of CoCl2 (Figure 4D). In
a second HIF-1 GOF model, we analyzed COX4-1 levels
in HeLa cells that were infected with an adenovirus encod-
ing either b-galactosidase (AdLacZ) or a constitutively ac-
tive form of HIF-1a (AdCA5) that activates target gene ex-
pression under nonhypoxic conditions (Kelly et al., 2003).
COX4-1 levels were dramatically reduced by infectionwith
AdCA5 as compared to AdLacZ (Figure 4E). Thus, HIF-1
GOF leads to loss of COX4-1 protein expression.
We also investigated the effect of HIF-1 LOF using two
independent experimental approaches. In wild-type
mouse embryo fibroblasts, which express HIF-1a but
not HIF-2a, COX4-1 protein levels were reduced in
response to hypoxia, whereas in HIF-1a null cells, no in-
duction of HIF-1a or loss of COX4-1 protein occurred
(Figure 4F). In the second LOF approach, expression of
Shr-HIF-1a in HeLa cells partially inhibited the induction
of HIF-1a in response to CoCl2 and partially inhibited theloss of COX4-1 protein in response to CoCl2, whereas
b-actin protein levels were unaffected by CoCl2 or Shr-
HIF-1a (Figure 4G).
To investigate the mechanism by which COX4-1 was
degraded in response to hypoxia, cells were treated with
the proteasome inhibitor MG132, which blocks HIF-1a
degradation (Figure 4H). However, CoCl2-induced degra-
dation of COX4-1 was not blocked by MG132. In pulse-
chase assays, degradation of COX4-1 was dramatically
increased by CoCl2 (Figure 4I). The results presented in
Figure 4 demonstrate that COX4-1 degradation is induced
in cells exposed to hypoxia or CoCl2 by a HIF-1-depen-
dent, proteasome-independent mechanism.
HIF-1 Regulates a Mitochondrial Protease
that Is Required for COX4-1 Degradation
The activity of the mitochondrial protease LON is induced
by hypoxia, ischemia, or endoplasmic reticulum stressCell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc. 115
Figure 4. O2-Dependent Regulation of
COX4-1 Protein Levels
(A) Immunoblot assay of HIF-1a, COX4-1, and
b-actin protein in HeLa and Hct116 cells that
were treated with vehicle () or 100 mM CoCl2
(+) for 24 or 48 hr.
(B) HeLa cells were exposed to CoCl2 as indi-
cated, and lysates were analyzed for expres-
sion of COX4-1, HIF-1a, and b-actin protein.
(C) Cells were untreated (No) or treated with
CoCl2 (Co), dimethyloxalylglycine (Do), or dihy-
droxybenzoate (Dh). Whole-cell lysates were
prepared after 4 hr for HIF-1a or after 24 hr
for COX4-1 and b-actin immunoblot assays.
(D) RCC4 cells, which lack VHL expression, and
RCC4-VHL cells, which are stably transfected
with a VHL expression vector, were untreated
() or treated with CoCl2 for 24 hr (+), and ly-
sates were subjected to HIF-1a, COX4-1, and
b-actin immunoblot assays.
(E) HeLa cells were infected with 50 plaque-
forming units per cell of AdLacZ or AdCA5,
and lysates were analyzed 24 hr after infection.
(F) Mouse embryo fibroblasts that were wild-
type (WT) or homozygous for a knockout (KO)
allele at the locus encoding HIF-1a were incu-
bated at 20% or 1% O2. Whole-cell lysates
were prepared after 4 hr for HIF-1a or after
24 hr for COX4-1 and b-actin immunoblot as-
says.
(G) HeLa cells were transfected with vector (+)
encoding short-hairpin RNA against HIF-1a
(Shr-HIF-1a), HIF-2a (Shr-HIF-2a), or empty
vector () and exposed to vehicle or CoCl2 for
24 hr prior to immunoblot assays.
(H) Cells were untreated () or CoCl2-treated
(+) for 24 hr with 10 mM MG132 or vehicle
added for the last 4 hr.
(I) Cells were pulsed with [35S]-methionine and
chased with unlabeled methionine for 0, 4, or
8 hr in the absence (control) or presence of
CoCl2 followed by immunoprecipitation of
COX4-1, PAGE, autoradiography (left), and
quantification (right; mean ± SEM, n = 3).(Hori et al., 2002). We hypothesized that LON is responsi-
ble for hypoxia-induced degradation of COX4-1. LON
mRNA expression was induced in: HeLa cells exposed
to 1% O2 for 24 or 48 hr (Figures 5A and S8); heart, lung,
and liver of hypoxic mice (Figure 5B); and AdCA5-infected
cells (Figure 5C). LON mRNA expression was induced
by hypoxia in RCC4-VHL cells but was constitutively
expressed in the VHL-deficient parental RCC4 cells
(Figure 5D, left panels). RCC4 cells stably transfected
with expression vector encoding Shr-HIF-1a expressed
lower levels of LON mRNA than did RCC4 cells trans-
fected with empty vector (Figure 5D, right panels). Com-
pared to scrambled control shRNA, shRNA against LON
mRNA blocked degradation of COX4-1 protein that was
induced by hypoxia or CoCl2 (Figure 5E).
Analysis of the human LON gene promoter revealed the
presence of five potential HIF-1-binding sites within 0.6 kb
50 to the transcription start site (Figure S9). Activity of the116 Cell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc.full-length promoter was markedly induced by hypoxia,
and deletion analysis suggested that the middle and prox-
imal, but not distal, candidate HIF-1 sites contributed to
the response in HeLa (Figure 5F) and 293 (Figure S10)
cells. These results were corroborated by ChIP assays,
which demonstrated the binding of protein complexes
containing HIF-1a and HIF-2a to the proximal and middle,
but not distal, HIF-1 sites in DFX-treated, but not in un-
treated, HeLa cells (Figure 5G). The data presented in Fig-
ure 5 indicate that HIF-1 induces LON expression and that
LON is required for the degradation of COX4-1 protein in
hypoxic cells.
Functional Consequences of Modulating
COX4 Subunit Expression
Little is known regarding the functional properties of the
humanCOX4-1 and COX4-2 proteins.We analyzed the ef-
fect of increasing (Figure S11) or decreasing (Figures S12
Figure 5. Regulation of LON Mitochon-
drial Protease Expression
(A and B) LONmRNA expression relative to 18S
rRNA was determined by RT-PCR and qrtPCR
(mean ±SEM, n = 3) in: (A) HeLa cells incubated
for 24 hr at 20% or 1% O2 and (B) tissues from
mice exposed to 10% or 21% O2 for 3 weeks.
(C) LONmRNA expression in control HeLa cells
(Con) and cells infectedwith AdLacZ or AdCA5.
(D) LON mRNA expression was analyzed in
RCC4 and RCC4-VHL cells incubated at 1%
or 20% O2 and RCC4 cells stably transfected
with empty vector (EV) or expression vector
encoding short-hairpin RNA (Shr) against
HIF-1a (ShrHIF-1a).
(E) Effect of LON loss-of-function (LOF) on the
expression of COX4-1 is shown. Cells were
transfected with an expression vector encod-
ing Shr-targeting LON mRNA (ShrLON) or a
scrambled control sequence (Scr) and were
exposed to no treatment (No), CoCl2 (Co), or
hypoxia (Hy) for 24 hr. COX4-1 and b-actin pro-
tein levels in cell lysates were determined by
immunoblot assays.
(F) HeLa cells were transfected with luciferase
reporter plasmids with LON promoter se-
quences containing candidate HIF-1-binding
sites (ovals) and incubated for 24 hr at 20% or
1% O2.
(G) HIF-1 binding to LON gene sequences was
analyzed by ChIP. Chromatin from cells that
were exposed to vehicle (Control) or to desfer-
rioxamine (DFX) was immunoprecipitated
(ChIP) with IgG, anti-HIF-1a, or anti-
HIF-2a antibody and analyzed by PCR using
primers spanning candidate HIF-1-binding
sites. gDNA is a positive control in which
PCR was performed using total human geno-
mic DNA rather than immunoprecipitated
chromatin.and S13) the levels of these proteins in 293T cells cultured
under nonhypoxic and hypoxic conditions. 293T cells
were transiently transfected with expression vectors en-
coding either FLAG- or V5-epitope-tagged COX4-1 or
COX4-2 protein. Immunoblot assays revealed that all
four proteins were expressed at high levels and localized
to the mitochondrial fraction of cell lysates (Figure S14),
and all subsequent experiments were performed with
FLAG-tagged proteins.
Compared to cells transfected with EV, nonhypoxic
cells transfected with vector encoding COX4-1 mani-
fested modest, but significant, increases in COX activity
and O2 consumption (COX and JO2, respectively, in
Figure 6A, left panels), which is consistent with the already
high level of COX4-1 in these cells (Figure S12). COX4-2
GOF also increased COX and JO2 in nonhypoxic cells.
COX4-2, but not COX4-1, increased COX and JO2 in hyp-
oxic cells. Immunoblot assay revealed that overexpres-
sion of FLAG-COX4-1 successfully overwhelmed the pro-
teolytic machinery in hypoxic cells (Figure S11), thus ruling
out the possibility that the ineffectiveness of FLAG-COX4-1
to increase COX and JO2 in hypoxic cells was due to itsdegradation. ATP levels were increased in nonhypoxic
cells with either COX4-1 or COX4-2 GOF, but only
COX4-2 GOF increased ATP levels in hypoxic cells.
COX4-1 LOF led to a reduction in COX, JO2, and ATP in
nonhypoxic cells but had no effect on these indices in hyp-
oxic cells (Figure 6A, right panels). COX4-2 LOF had no
effect in nonhypoxic cells but led to reduced COX, JO2,
and ATP in hypoxic cells.
We hypothesized that COX4-1 and COX4-2 may be
necessary to optimize electron transfer chain activity un-
der nonhypoxic and hypoxic conditions, respectively.
Nonoptimal efficiency may result in decreased ATP pro-
duction and/or increased production of H2O2 due to reac-
tion of electrons with O2 prior to complex IV. H2O2 levels
increased in response to hypoxia, an effect that was in-
creased by COX4-1 GOF and decreased by COX4-2
GOF (Figure 6A, left panels). COX4-1 and COX4-2 LOF se-
lectively increased H2O2 levels in nonhypoxic and hypoxic
cells, respectively. Activation of caspase 3 was increased
in hypoxic cells, an effect that was amplified by COX4-1
GOF, whereas COX4-2 GOF increased caspase activation
in nonhypoxic cells. COX4-1 and COX4-2 LOF selectivelyCell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc. 117
Figure 6. Effects of Altered COX4 Subunit Expression on Cellular Homeostasis
(A) 293T cells were transiently transfected with empty vector (EV), FLAG-COX4-1, or FLAG-COX4-2 (left panels) or with vector encoding short-hairpin
RNA (Shr) with no target (Scr) or targeting COX4-1 (Shr4-1) or COX4-2 (Shr4-2) mRNA (right panels) and incubated under nonhypoxic (red bars) or
hypoxic (blue bars) conditions for 24 hr, followed by determination of mean (± SEM) cytochrome c oxidase activity (COX), O2 consumption (JO2),
ATP, H2O2, and activated caspase 3 activity. *, p < 0.05 compared to Scr/EV;
#, p < 0.05 for indicated comparison.
(B) 293T cells were transiently transfected with expression vectors encoding scrambled negative control (Scr), COX4-1 (Shr4-1), or COX4-2 (Shr4-2)
shRNA and incubated at 20% (left) or 1% (right) O2. Cells were harvested 24 or 48 hr later, and the number of viable cells was determined by trypan
blue exclusion. Mean values are shown (± SEM, n = 3); *, p < 0.05 by Student’s t test compared to Scr.
(C) Left panels: 293T cells were transiently transfected with: vector encoding Shr with no target (Scr) or Shr resulting in COX4-1 (Shr4-1) LOF and EV or
vector for COX4-1 (4-1) or COX4-2 (4-2) gain-of-function (GOF). Right panels: 293T cells were transfected with: vector encoding Shr with no target
(Scr) or Shr resulting in COX4-2 (Shr4-2) LOF and EV or vector for COX4-1 (4-1) or COX4-2 (4-2) GOF. Cells were incubated under nonhypoxic (red
bars) or hypoxic (blue bars) conditions for 24 hr, followed by determination ofmean (±SEM) JO2, ATP, and H2O2. *, p < 0.05 compared to Scr/EV;
#, p <
0.05 for indicated comparison (Student’s t test). For all panels, each graph represents an independent experiment, andmean ±SEM (n = 3) are shown.increased caspase activation in nonhypoxic and hypoxic
cells, respectively (Figure 6A, right panels). Trypan blue
staining revealed that COX4-1 LOF led to a selective re-
duction in the number of viable cells under nonhypoxic
conditions, whereas COX4-2 LOF led to selective reduc-
tion in the number of viable cells under hypoxic conditions
(Figure 6B). All of these experiments were also performed
in HeLa cells with similar results (Figures S15 and S16).
We next performed subunit rescue assays. The effects
of COX4-1 LOF on JO2, ATP, and H2O2 levels could be
rescued by COX4-1 expression vector (Figure 6C, left
panels) even though the increase in COX4-1 protein levels
was modest (Figure S17). Overexpression of COX4-2 also
rescued COX4-1 LOF. In contrast, the effects of COX4-2
LOF on JO2, ATP, and H2O2 levels could be rescued
by COX4-2, but not by COX4-1, GOF (Figure 6C, right118 Cell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc.panels). All of these experiments were also performed in
HeLa cells with similar results (Figure S18). The data pre-
sented in Figure 6 demonstrate that in hypoxic cells
COX4-2 plays a unique and essential role. In nonhypoxic
cells, COX4-1 GOF increased COX, JO2, and ATP without
increasing levels of H2O2 and activated caspase 3,
whereas COX4-2 increased COX, JO2, and ATP as well
as H2O2 and activated caspase. Taken together, the com-
prehensive analyses we have performed indicate that the
COX4 subunit switch constitutes a critical adaptive re-
sponse to hypoxia.
DISCUSSION
In this study we demonstrate that COX structure and
function are regulated in response to changes in the
oxygenation of mammalian cells. In a striking example of
convergent evolution, mammalian COX4 and yeast
COX5 subunit expression are both regulated in an O2-
dependent manner. However, the molecular mechanisms
underlying this common strategy for regulating COX activ-
ity differ (Figure 7). In Saccharomyces cerevisiae, COX5a
transcription is activated by the Hap2/3/4/5 protein and
COX5b transcription is repressed by the Rox1 protein
under aerobic conditions, whereas under hypoxic con-
ditions, COX5a transcription is no longer activated and
COX5b is no longer repressed (Burke and Poyton, 1998).
The involvement of O2 in this pathway is indirect: Hap2/
3/4/5 and Hap1 (the transactivator of Rox1) are activated
by binding heme, which is only synthesized under aerobic
conditions.
In hypoxic mammalian cells, HIF-1, which is negatively
regulated by O2-dependent hydroxylation, activates tran-
scription of the COX4I2 and LON genes, which leads to
increased COX4-2 mRNA and protein synthesis and
increased COX4-1 proteolysis. Both HIF-1a and HIF-2a
contribute to the regulation of LON gene expression (Fig-
ure 5), whereas knockdown of HIF-1a but not HIF-2a
blocks COX4-1 degradation (Figure 4G). Further studies
Figure 7. Mechanisms and Consequences of O2-Regulated
COX Subunit Switching
In yeast (left) growing under aerobic conditions that are permissive for
heme synthesis, Hap2/3/4/5 transactivates theCOX5a gene and Hap1
transactivates the Rox1 gene, the protein product of which represses
COX5b transcription. Under hypoxic conditions, inhibition of heme
synthesis results in loss of Hap2/3/4/5 and Hap1 activity, loss of
COX5a transcription, and derepression of COX5b transcription. In
mammals (right), HIF-1 activity is inhibited by prolyl (HPH1-3) and
asparaginyl (FIH-1) hydroxylases, which utilize O2 as a substrate to
hydroxylate HIF-1a and HIF-2a. In hypoxic cells, hydroxylation is
inhibited, leading to HIF-1-mediated transactivation of the COX4I2
gene, which encodes COX4-2, and the LON gene, which encodes
a protease that is required for the degradation of COX4-1. In yeast
and mammals, COX subunit switching represents a homeostatic
mechanism to maintain optimal efficiency of mitochondrial respiration
in response to changes in cellular oxygenation.are necessary to determine whether other mitochondrial
proteases that are regulated exclusively by HIF-1a may
participate in the degradation of COX4-1. While this
work was in progress, reduced levels of COX4-1 in
CoCl2-treated cells were reported by investigators who
concluded that inhibition of precursor processing led to
degradation of the protein (Hervouet et al., 2006), but
they did not identify the protease nor observe the induc-
tion of COX4-2 expression that is critical for the subunit
switching phenomenon we have demonstrated.
Mammalian COX4 and yeast COX5 have remarkably
similar structures and functions. The crystal structure de-
termined for bovine COX4-1 (Tsukihara et al., 1996) and
the predicted three-dimensional structure of yeast
COX5a are superimposable, thus allowing a similar pre-
dicted spatial relationship between these proteins and
the catalytic COX1 andCOX2 subunits (Burke and Poyton,
1998). Both mammalian COX4 and yeast COX5 are re-
quired for proper assembly of COX1, COX2, and COX3
(McEwen et al., 1986; Nijtmans et al., 1998). Most impor-
tantly, complexes containing the hypoxic COX5b subunit
have higher TNmax values at low O2 concentrations than
do complexes containing the aerobic COX5a subunit
(Waterland et al., 1991; Allen et al., 1995).
Our data indicate that the switch fromCOX4-1 toCOX4-2
inmammalian cells represents a similar adaptive response
that optimizes COX activity under hypoxic conditions.
COX4-2 and LON mRNA expression are induced by
hypoxia in the liver and lungs of mice exposed to 10%
O2, indicating that the pathway we have delineated repre-
sents a physiological response to hypoxia. In considering
the factors that determine how respiratory chain function
is optimized at any given O2 concentration, we hypothe-
size that a balance is maintained between transfer of elec-
trons to O2 at complex IV to formwater as opposed to pre-
mature electron transfer at complex I or complex III to form
superoxide radical, which is converted to H2O2 by super-
oxide dismutase. Our demonstration that the effect of ma-
nipulating COX4-1 and COX4-2 expression on H2O2 levels
is O2 dependent provides strong support for this model.
Recent studies have demonstrated that respiration is
also O2-regulated at an earlier step, the conversion of py-
ruvate to acetyl CoA by pyruvate dehydrogenase, which is
inactivated when phosphorylated by pyruvate dehydroge-
nase kinase 1 (PDK1), the product of a HIF-1 target gene
(Kim et al., 2006; Papandreou et al., 2006). Hypoxic HIF-
1a null mouse embryo fibroblasts undergo apoptosis
caused by increased ROS production and are rescued
by forced expression of PDK1 (Kim et al., 2006). Whereas
PDK1 reduces tricarboxylic acid cycle activity and flux
through the respiratory chain, COX4 subunit switching
provides amechanism to maximize the efficiency of respi-
ration under conditions of reduced O2 availability. The ex-
tent to which PDK1 expression or COX4 subunit switching
is utilized as a strategy for maintaining oxygen homeosta-
sis may be tissue specific, as evidenced by the induction
of COX4-2 and LON mRNA expression in several, but not
all, tissues of chronically hypoxic mice (Figures 1E andCell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc. 119
5B). These results are consistent with previous studies
demonstrating that the battery of HIF-1 target genes ex-
pressed in response to hypoxia differ from one cell type
to another (Kelly et al., 2003). Further studies are required
to investigate the adaptive significance of tissue-specific
metabolic responses to hypoxia. HIF-1 also plays a key
role in regulating glycolysis, and analysis of cells cultured
in the presence of galactose and glutamine rather than
glucose (in order to eliminate glycolytic metabolism) may
provide additional mechanistic insight.
While these strategies may be focused on preventing
the generation of toxic levels of ROS, physiological levels
of ROS generated by complex I (Bonnet et al., 2006) or
complex III (Brunelle et al., 2005; Guzy et al., 2005; Mans-
field et al., 2005) may play an important signaling role in
the inhibition of hydroxylase activity under hypoxic con-
ditions that leads to HIF-1 activation. The complexity of
mitochondrial function reflects the critical role of this
organelle in generating ATP and ROS and, when intracel-
lular adaptation fails to balance these factors, in triggering
programmed cell death. The remarkable similarities in the
regulation of COX activity in yeast and human cells indi-
cate that the selection for O2-dependent homeostatic reg-
ulation of mitochondrial respiration is ancient and likely to
be shared by all eukaryotic organisms.
EXPERIMENTAL PROCEDURES
Tissue Culture
Cells were cultured in DMEM (293, 293T, HeLa, Hep3B, A495, and
RCC4) or McCoy’s 5A medium (HCT116) with 10% FBS (Gibco).
Mouse embryo fibroblasts were cultured in DMEM with 15% FBS.
Mouse pulmonary artery smooth muscle cells were cultured as de-
scribed (Wang et al., 2006). Cells were maintained in 5% CO2/95%
air at 37C. For hypoxic exposure, cells were placed in a modular incu-
bator chamber (Billups-Rothenberg) that was flushed with 1% O2/5%
CO2/balance N2 and incubated at 37
C. Other reagents were from
Sigma (CoCl2 and DFX), Frontier Scientific (DMOG), Calbiochem
(MG132), and Aldrich (DHB).
RT-PCR and qrtPCR
Total RNA was extracted from cells and tissue using Trizol (Invitrogen)
and treated with DNaseI (Ambion). One microgram of total RNA was
used for first-strand DNA synthesis using iScript cDNA Synthesis sys-
tem (BioRad), and PCR was performed using primers shown in Table
S1. qrtPCR was performed as described (Kelly et al., 2003). The
hypoxia-induced change in target mRNA expression was calculated
based on the threshold cycle (Ct) as 2D(DCt), where DCt = Cttarget 
Ct18S and D(DCt) = DCt1%  DCt20%.
Luciferase Reporter Assays
COX4I1 and COX4I2 sequences were amplified from human genomic
DNA by PCR using primers with MluI and BglII restriction sites (Table
S1), digested, and ligated into pGL2-Basic (Promega), which encodes
firefly luciferase. LON sequenceswere amplified, digested, and ligated
into pGL2-Promoter. Mutations were introduced into both HREs in
COX4I2 by using mutated PCR primers (Table S1). 4 3 104 cells
were transfected with firefly luciferase reporter plasmid (200 ng) and
control reporter plasmid pSV-Renilla (40 ng), which encodes Renilla
luciferase, using Fugene-6 (Roche). In GOF/LOF studies, cells
were transfected with pSV-Renilla, luciferase reporter (100 ng), and
100 ng of pSUPER vector encoding shRNA, pcDNA3.1 vector encod-
ing HIF-1a or HIF-2a, or pCEP4 expression vector encoding HIF-1aDN120 Cell 129, 111–122, April 6, 2007 ª2007 Elsevier Inc.plasmid. The ratio of firefly toRenilla luciferase activity was determined
using the Dual-Luciferase Assay System (Promega).
Immunoblot Assays
Whole-cell lysates were prepared in RIPA buffer and fractionated by
SDS-PAGE. Primary antibodies against the following proteins were
used: HIF-1a, HIF-2a, and HIF-1b (Novus Biologicals); b-actin (Santa
Cruz); FLAG (Sigma); and COX4 (Abcam). A polyclonal antibody
against COX4-2 was raised in a rabbit using a peptide corresponding
to human COX4-2 amino acids 133–145. HRP-conjugated anti-rabbit
(Roche), -mouse, and -goat (Santa Cruz) secondary antibodies were
used. Signal was detected using ECL Plus (GE Healthcore).
ShRNA and COX Expression Vectors
The shRNA targeting sequences are shown in Table S1. shRNA oligo-
nucleotides were annealed and ligated into BglII/HindIII-digested
pSUPER-retro-puro (OligoEngine). A 19 nt scrambled negative control
vector was also prepared (Okuyama et al., 2006). COX4-1- and COX4-
2-coding sequences were reverse transcribed from 293 and Hep3B
mRNA, amplified from cDNA using Pfu polymerase (Stratagene), and
ligated into pCR-BluntII-TOPO (Invitrogen). Coding sequences were
amplified with primers containing HindIII (50-end) and BglII (30-end)
restriction sites, digested, and ligated into p3xFLAG-CMV-7 (Sigma).
ChIP Assays
Cells were treated with vehicle or 100 mM DFX for 4 hr, 1% formalde-
hyde for 10 min, and 0.125 M glycine for 5 min and analyzed using the
Chromatin Immunoprecipitation Assay (Upstate) with anti-HIF-1a and
HIF-2a antibodies (Novus) and rabbit IgG (Santa Cruz). PCR was
performed using primers (Table S1) to amplify DNA sequences from
the COX4I2 or LON gene.
Adenoviral and Retroviral Transduction
HeLa cells were infected with 50 plaque-forming units per cell of ade-
novirus AdCA5 or AdLacZ and analyzed 24 hr later (Kelly et al., 2003).
RCC4 cells were stably transduced with retrovirus rvShRNAHIF-1a
(Krishnamachary et al., 2006).
Pulse-Chase Labeling of COX4-1
0.5 3 106 HeLa cells were plated in 6 cm dishes, exposed to 100 mM
CoCl2 for 16 hr, and labeled with [
35S]methionine (200 mCi/ml;
Amersham Pharmacia Biotech) for 40 min, which was followed by
incubation for 4–8 hr in standard culture medium. Whole-cell lysates
were prepared using 10 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,
1% NP-40, 0.1% SDS, 1% deoxycholate, and 1 mM PMSF; immuno-
precipitated with anti-COX4 antibody (Abcam); and subjected to SDS-
PAGE followed by autoradiography.
COX, ATP, O2-Consumption, H2O2, and Caspase Assays
Mitochondrial fractions isolated from HeLa and 293T cells were
analyzed by Cytochrome c Oxidase Assay (Sigma). ATP levels were
measured by Somatic Cell ATP Assay (Sigma). To measure O2 con-
sumption, cells were transfected and after 24 hr incubated in 20% or
1% O2 for 24 hr, removed from the chamber, and resuspended in
DMEM at 3 3 106 cells/ml; then 350 ml was analyzed using an
Oxygraph (Hansatec Instruments). To measure H2O2, cells were
transfected and incubated for 24 hr at 20% or 1% O2. Lysates were
prepared in M-PRE (Pierce), and 50 ml were analyzed by Amplex Red
Hydrogen Peroxide Assay (Invitrogen). Caspase activities were mea-
sured using Caspase-Glo 3/7 Assay kit (Promega). Cells were plated
in white-wall 96-well plate and transfected either with FLAG-tagged
COX4 expression plasmids or COX4-shRNA plasmids. After 24 hr,
cells were exposed to 1% O2 for 24 hr. Lysis of hypoxic cells and
H2O2 and caspase analysis were performed inside a hypoxic chamber
to avoid reoxygenation.
Statistical Analysis
Data are presented as mean ± SEM of at least three independent ex-
periments. Statistical significance (p < 0.05) was assessed by t test.
Supplemental Data
Supplemental Data include eighteen figures and one table and can be
found with this article online at http://www.cell.com/cgi/content/full/
129/1/111/DC1/.
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